NCT04451941

Brief Summary

Determination of clinical effects of brain machine interface in chronic stroke patient without wrist extensor strength

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at P25-P50 for not_applicable stroke

Timeline
Completed

Started Jul 2020

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 4, 2020

Completed
26 days until next milestone

First Posted

Study publicly available on registry

June 30, 2020

Completed
1 day until next milestone

Study Start

First participant enrolled

July 1, 2020

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2021

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2021

Completed
Last Updated

July 31, 2020

Status Verified

July 1, 2020

Enrollment Period

1.4 years

First QC Date

June 4, 2020

Last Update Submit

July 30, 2020

Conditions

Keywords

brain machine interfacechronic strokewrist extensor strength

Outcome Measures

Primary Outcomes (1)

  • Fugl-Meyer Assessment - upper extremity

    Fugl-Meyer Assessment is indicator of the level of impairment of upper extremity, with higher scores indicating lower impairment. Total scores range from 0 to 66, each item being scored on a 3-point scale (0, cannot perform; 1, partially performs; and 2, fully performs the task).

    4 weeks after baseline

Secondary Outcomes (13)

  • Box and block test

    baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline

  • Jebsen hand function test

    baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline

  • 9-hole peg test

    baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline

  • Medical Research Council (MRC) scale of affected upper extremity

    baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline

  • Joint position sense

    baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline

  • +8 more secondary outcomes

Study Arms (2)

RecoveriX with individual EEG calibration

EXPERIMENTAL

RecoveriX applied functional electrical stimulation (FES) according to individual brainwave by individual EEG calibration for 4 weeks

Device: Experimental: RecoveriX with individual EEG calibration

RecoveriX without individual EEG calibration

SHAM COMPARATOR

RecoveriX applied FES according to the brainwave of other subjects regardless of the individual brainwave for 4 weeks

Device: RecoveriX without individual EEG calibration

Interventions

RecoveriX applied FES according to individual brainwave by individual EEG calibration for 5 times a week for 4 weeks

RecoveriX with individual EEG calibration

RecoveriX applied FES according to the brainwave of other subjects regardless of the individual brainwave for 5 times a week for 4 weeks

RecoveriX without individual EEG calibration

Eligibility Criteria

Age19 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Hemiplegic patients secondary to first cerebrovascular accidents
  • Weak wrist extension
  • Onset ≥ 6 months
  • Fugl-Meyer Assessment score ≥ 19
  • Cognitively intact enough to understand and follow the instructions from the investigator

You may not qualify if:

  • Wrist extensor spasticity above or modified ashworth scale 2
  • Severe upper extremity pain that could interfere with rehabilitation therapy
  • Neurological disorders other than stroke that can cause motor deficits
  • Uncontrolled severe medical conditions.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Rehabilitation Center

Seoul, 142884, South Korea

RECRUITING

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Joon-Ho Shin

    National Rehabilitation Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chief of Brain Injury Rehabilitation Department, Principal Investigator

Study Record Dates

First Submitted

June 4, 2020

First Posted

June 30, 2020

Study Start

July 1, 2020

Primary Completion

December 1, 2021

Study Completion

December 31, 2021

Last Updated

July 31, 2020

Record last verified: 2020-07

Locations